OTCMKTS:ORTIF Ortho Regenerative Technologies (ORTIF) Stock Price, News & Analysis → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free ORTIF Stock Alerts $0.20 0.00 (0.00%) (As of 09/9/2022) Add Compare Share Share Today's Range$0.20▼$0.2050-Day Range$0.20▼$0.2052-Week Range$0.13▼$0.45VolumeN/AAverage Volume3,282 shsMarket Capitalization$6.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Ortho Regenerative Technologies alerts: Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. About Ortho Regenerative Technologies Stock (OTCMKTS:ORTIF)Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.Read More ORTIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ORTIF Stock News HeadlinesOctober 1, 2023 | proactiveinvestors.comChitogenX ends 2Q with stronger balance sheet as it advances its... ChitogenX ends 2Q with stronger balance sheet as it advances its...October 1, 2023 | seekingalpha.comOrtho Regenerative Technologies reports Q2 resultsApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...September 27, 2023 | wsj.comMedprin Regenerative Medical Technologies Co. Ltd. AAugust 11, 2023 | uk.investing.comMedprin Regenerative Medical Technologies Co Ltd (301033)April 8, 2023 | markets.businessinsider.comChitogenX (CHNXF) Gets a Buy from Noble FinancialApril 7, 2023 | marketwatch.comOrthopedic Regenerative Surgical Products Market Revenue, Demand Status, Top Regions and Leading Players Analysis till 2030February 22, 2023 | marketwatch.comOrtho Phthalic Aldehyde Market Research Report 2023 By Leading Players, Emerging Technologies, Opportunity 2029April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...February 11, 2023 | finance.yahoo.comSt. Vincent's Orthopedics joins Hughston Clinic's OrganizationJanuary 7, 2023 | health.usnews.comBest Hospitals for OrthopedicsOctober 15, 2022 | proactiveinvestors.comChitogenX shares jump on launch of its second orthopedic development program in meniscus repairSeptember 22, 2022 | newsweek.comTop Specialized Hospitals - OrthopedicsSeptember 10, 2022 | finance.yahoo.comHope Orthopedics of Oregon Expands Hand/Wrist Service with Dr. Allison MitchellSeptember 8, 2022 | seekingalpha.comOrtho Regenerative Technologies announces name change to ChitogenX Inc.September 7, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENXJuly 27, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIALJune 24, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTSJune 13, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIALMay 26, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIRMay 21, 2022 | seekingalpha.comOrtho Regenerative Technologies; GAAP EPS of -C$0.14May 20, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTSMay 4, 2022 | seekingalpha.comOrtho Regenerative gets US patent related to its soft tissue repair platformMay 4, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORMApril 6, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT FOR $3.2 MILLIONMarch 24, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES TO PARTICIPATE IN THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC AND HOSTED BY M-VESTMarch 21, 2022 | finance.yahoo.comORTHO REGENERATIVE TECHNOLOGIES AMENDS THE TERMS OF ITS $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITSSee More Headlines Receive ORTIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ortho Regenerative Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical Appliances & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:ORTIF CUSIPN/A CIKN/A Webwww.orthorti.com Phone(514) 782-0951FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,930,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-269.68% Debt Debt-to-Equity RatioN/A Current Ratio1.26 Quick Ratio1.26 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.16) per share Price / Book-1.23Miscellaneous Outstanding Shares34,956,000Free FloatN/AMarket Cap$6.86 million OptionableNot Optionable Beta-1.16 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Luc Mainville M.B.A (Age 58)M.B.A., Sr. VP & CFO Comp: $53.85kMr. Guy-Paul AllardVP of Legal Affairs & Corp. Sec.Mr. Philippe Deschamps (Age 60)CEO, Pres & Director Mr. Frederic DumaisDirector of Communications & Investor RelationsDr. Jonathan SackierChief Medical OfficerBenedek SimoControllerMore ExecutivesKey CompetitorsHeart Test LaboratoriesNASDAQ:HSCSPredictive OncologyNASDAQ:POAINanoVibronixNASDAQ:NAOVMangoceuticalsNASDAQ:MGRXOntrakNASDAQ:OTRKView All Competitors ORTIF Stock Analysis - Frequently Asked Questions How have ORTIF shares performed in 2024? Ortho Regenerative Technologies' stock was trading at $0.1962 on January 1st, 2024. Since then, ORTIF stock has increased by 0.0% and is now trading at $0.1962. View the best growth stocks for 2024 here. How do I buy shares of Ortho Regenerative Technologies? Shares of ORTIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ORTIF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ortho Regenerative Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
